Latest News & Features
Europe
The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF. 18 February 2016
Americas
The US Federal Trade Commission has waded into a competition dispute at the US Court of Appeals for the Federal Circuit centring on ‘reverse payment’ settlements. 18 February 2016
Americas
During nearly 30 years as a US Supreme Court justice, Antonin Scalia had the unenviable tasks of ruling on homosexuality, the right to carry hand guns, and abortion. Nevertheless, it was a mystery patent case that proved the most difficult. WIPR looks back at some of the most important IP cases of the past few years and how Scalia voted on them. 18 February 2016
Americas
Sandoz has petitioned the US Supreme Court to review the US Court of Appeals for the Federal Circuit’s ruling in the ‘patent dance’ dispute. 17 February 2016
Americas
Galderma Laboratories has successfully avoided three inter partes review petitions being instituted against a patent covering its Oracea (doxycycline, USP) drug, used to treat skin condition rosacea. 17 February 2016
Americas
Law firm Reed Smith has expanded its intellectual property, information and innovation group by hiring Lisa Chiarini as a partner in New York. 17 February 2016
Americas
Accord Healthcare’s attempt to market a generic version of Pfizer’s Tygacil has hit a brick wall after it was accused of infringing three patents. 16 February 2016
Americas
Law firm Steptoe & Johnson has hired Ying Li as a partner in the firm’s intellectual property group in New York. 16 February 2016
Big Pharma
Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta. 15 February 2016
Africa
GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat. 12 February 2016